anemia
r-Hu-EPO at a dose of either 150 or 300 IU/kg three times weekly delays the onset of anemia and reduces RBC transfusion requirements in patients who undergo intensive chemotherapy for SCLC.
r-Hu-<span class="gene" id="7602351-12-5-8">EPO</span> at a dose of either 150 or 300 IU/kg three times weekly delays the onset of <span class="disease" id="7602351-12-85-91">anemia</span> and reduces RBC transfusion requirements in patients who undergo intensive chemotherapy for SCLC.